APA (7th ed.) Citation

S, K., M, S., Y, Y., S, I., Y, K., R, K., . . . N, H. (2026). CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect. Cancer immunology, immunotherapy : CII, 75(3), . https://doi.org/10.1007/s00262-026-04342-x

Chicago Style (17th ed.) Citation

S, Kida, et al. "CAR T Cells Derived from a Novel, High-affinity Anti-CLL-1 Monoclonal Antibody Exhibit a Significant Anti-AML Effect." Cancer Immunology, Immunotherapy : CII 75, no. 3 (2026). https://doi.org/10.1007/s00262-026-04342-x.

MLA (9th ed.) Citation

S, Kida, et al. "CAR T Cells Derived from a Novel, High-affinity Anti-CLL-1 Monoclonal Antibody Exhibit a Significant Anti-AML Effect." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 3, 2026, https://doi.org/10.1007/s00262-026-04342-x.